Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer identifies the site as revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record page now displays “TypeError: Failed to fetch” instead of a 403 Forbidden response, and the NIH transition notice is no longer shown.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide notice was added explaining NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.